Can pneumonia vaccines prevent mycoplasma pneumonia?

Written by Wang Xiang Yu
Pulmonology
Updated on November 11, 2024
00:00
00:00

Can pneumonia vaccines prevent Mycoplasma infections? First, we need to understand what pneumonia vaccines are. In our country, the most commonly used pneumonia vaccines are aimed at Streptococcus pneumoniae, which are divided into polysaccharide vaccines and conjugate vaccines. Polysaccharide vaccines are mainly suitable for individuals over two years old and include the 23-valent polysaccharide vaccine. This vaccine can prevent infections caused by twenty-three serotypes that often lead to S. pneumoniae infections, with over 90% of pneumonia caused by these twenty-three serotypes. However, the 23-valent polysaccharide vaccine does not prevent infections caused by other serotypes of S. pneumoniae. Additionally, the conjugate vaccine only prevents infections caused by either seven or thirteen serotypes. Since Mycoplasma is neither a bacterium nor a virus, it cannot be prevented by pneumonia vaccines, and currently, there is no vaccine available specifically for Mycoplasma infections.

Other Voices

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 18sec home-news-image

The function of the pneumonia vaccine

Pneumonia vaccines are generally aimed at preventing infections caused by Streptococcus pneumoniae. There are two common types of vaccines: the 23-valent polysaccharide vaccine, which is suitable for high-risk populations over two years old, and the 7-valent or 13-valent conjugate vaccines, which are mainly used for vaccinating infants under two years of age. Streptococcus pneumoniae is the most common and widespread bacterium causing pneumonia, and pneumonia caused by this bacterium is also the most prevalent worldwide. It is also the most significant pathogen in community-acquired pneumonia in children and a major cause of otitis media, meningitis, and bacteremia in children. The pneumonia vaccines mainly target common serotypes of Streptococcus pneumoniae, such as the 7-valent or 13-valent, designed to prevent infections from seven or thirteen serotypes, respectively, while the 23-valent vaccine aims to prevent infections from 23 serotypes. These pneumonia vaccines play a significant protective role in preventing infections caused by Streptococcus pneumoniae, however, they cannot prevent all cases of pneumonia.

doctor image
home-news-image
Written by Wang Xiang Yu
Pulmonology
1min 24sec home-news-image

Can pneumonia vaccines prevent mycoplasma pneumonia?

Can pneumonia vaccines prevent Mycoplasma infections? First, we need to understand what pneumonia vaccines are. In our country, the most commonly used pneumonia vaccines are aimed at Streptococcus pneumoniae, which are divided into polysaccharide vaccines and conjugate vaccines. Polysaccharide vaccines are mainly suitable for individuals over two years old and include the 23-valent polysaccharide vaccine. This vaccine can prevent infections caused by twenty-three serotypes that often lead to S. pneumoniae infections, with over 90% of pneumonia caused by these twenty-three serotypes. However, the 23-valent polysaccharide vaccine does not prevent infections caused by other serotypes of S. pneumoniae. Additionally, the conjugate vaccine only prevents infections caused by either seven or thirteen serotypes. Since Mycoplasma is neither a bacterium nor a virus, it cannot be prevented by pneumonia vaccines, and currently, there is no vaccine available specifically for Mycoplasma infections.

doctor image
home-news-image
Written by Han Shun Li
Pulmonology
45sec home-news-image

Is bronchopneumonia the same as pneumonia?

Some patients might ask if bronchopneumonia is a type of pneumonia. Undoubtedly, bronchopneumonia is a type of pneumonia, categorized anatomically. It can be classified into lobar pneumonia, bronchopneumonia, and interstitial pneumonia. During X-ray imaging, bronchopneumonia typically shows as irregular patchy shadows distributed along the lung markings, with soft and blurry edges, without signs of consolidation. It often occurs in the lower lobes of both lungs. The treatment principles for bronchopneumonia are similar to those for common pneumonia, mainly involving the use of antibiotics, cough suppressants and expectorants, fever reduction, and other symptomatic treatments.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
46sec home-news-image

Symptoms of pneumonia cough in children

Pneumonia in infants commonly occurs in young children, especially those under two years of age. The onset of the disease is usually rapid, starting with symptoms of upper respiratory tract infections that gradually evolve into more pronounced respiratory symptoms. The cough is frequent, initially a dry, irritating cough, that progressively worsens as the disease advances. In cases of severe pneumonia, the cough may actually lessen. During the recovery phase, the cough gradually diminishes and rattling sounds can be heard in the throat due to mucus. After the mucus is cleared, there may still be occasional bouts of irritating dry cough, which will slowly subside.

doctor image
home-news-image
Written by Yang Feng
Pulmonology
51sec home-news-image

Symptoms of pneumonia in children

Pneumonia is a particularly common infectious disease of the respiratory system, and infants and young children are especially susceptible to pneumonia because their immune systems are much weaker than those of healthy adults. When infants and young children develop pneumonia, their symptoms differ from adults; they often exhibit only fever, crying, nausea, vomiting, etc. The symptoms of coughing and phlegm are relatively less obvious, making the diagnosis of pneumonia in infants and young children somewhat more difficult. If a patient exhibits fever, auscultation and routine blood tests can be used to preliminarily determine the presence of an infection. If pneumonia is suspected, further comprehensive imaging examinations can be conducted to confirm the diagnosis.